Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients

Keyvan Karkouti, Jeannie Callum, Kenichi Tanaka, Deep Grewal, Cristina Solomon, Sigurd Knaub, Sylvia Werner, Jerrold H Levy

Blood (2023) 142 (Supplement 1): 5515.

https://doi.org/10.1182/blood-2023-186539

Published: 2023

Journal Articles

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Blood (2023) 142 (Supplement 1): 1295.

https://doi.org/10.1182/blood-2023-181541

Published: 2023

Journal Articles

Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study

Francesco Passamonti, MD, Francesca Palandri, MD PhD, Guray Saydam, MD, Miklos Egyed, MD PhD, Jeannie Callum, MD FRCPC, Timothy Devos, MD, Serdar Sivgin, MD, Paola Guglielmelli, MD, Alessandro M. Vannucchi, MD, Evren Zor, MD, Geralyn Gilotti, MSc, Yifan Zhang, PhD, Martin Griesshammer, MD PhD

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-139281

Published: 2020

Journal Articles

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Jeannie Callum, Calvin Yeh, MD PhD, Mark McVey, MD, Andrew Petrosoniak, MD, Stephanie Cope, Troy Thompson, BAHSc, Victoria Chin, Keyvan Karkouti, MD, Avery Nathans, MDMPH PhD, Kimmo Murto, MD, Suzanne Beno, MD, Jacob Pendergrast, MDFRCPC, Andrew McDonald, MDMSc, Neil Adhikari, MDM MSc, Asim Alam, MD, Donald M. Arnold, MD, Lee Barratt, Andrew Beckett, MD, Sue Brenneman, MD, Hina Chaudhry, BSc, Allison Collins, MD, Margaret Harvey, Jacinthe Lampron, MD, Russell MacDonald, MDMPH, Clarita Margarido, MD, Amanda McFarlan, Barto Nascimento, MDMSc, Wendy Owens, Menaka Pai, MSc, MD FRCPC, Sandro Rizoli, MD PhD, Theodora Ruijs, MD, Robert Skeate, PhD, Teresa Skelton, MD, Michelle Sholzberg, MDBSc,FRCPC,MSc, Kelly Syer, Jami-Lynn Viveiros, Josee Theriault, MD, Alan T. Tinmouth, MD FRCPC, Rardi Van Heest, MD, Susan White, Michelle P. Zeller, MD FRCPC, MHPE, Katerina Pavenski, MD

Blood (2019) 134 (Supplement_1): 5792.

https://doi.org/10.1182/blood-2019-121501

Published: 2019

Journal Articles

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Shangari Vijenthira, Chantal Armali, Helen Downie, Ann Wilson, Kathy Paton, Brian Berry, Christine Cserti-Gazdewich, Jeannie Callum

Blood (2019) 134 (Supplement_1): 3689.

https://doi.org/10.1182/blood-2019-130615

Published: 2019

Journal Articles

Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate

Leigh Minuk, MD, Jeannie Callum, Alan T. Tinmouth, MD FRCPC, Robert Skeate, PhD, Nancy Heddle, MSc, Donald M. Arnold, MD, Troy Thompson, BAHSc, Ziad Sohl, MD MSc, Nadine Shehata, MDFRCPC,MSc, Cyrus C. Hsia, MDBSc,FRCPC, Rebecca Barty, MLT, BA, MSc, Yang Liu, MS

Blood (2019) 134 (Supplement_1): 3695.

https://doi.org/10.1182/blood-2019-126232

Published: 2019

Journal Articles

Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study

Francesco Passamonti, MD, Francesca Palandri, PhD MD, Guray Saydam, MD, Giulia Benevolo, MD, Miklos Egyed, MD PhD, Jeannie Callum, MD, Timothy Devos, Serdar Sivgin, MD, Paola Guglielmelli, MD PhD, Alessandro M. Vannucchi, MD, Caroline Bensasson, Albert Kandra, Juliane Morando, MD, Martin Griesshammer, MD PhD

Blood (2018) 132 (Supplement 1): 1754.

https://doi.org/10.1182/blood-2018-99-115350

Published: 2018

Journal Articles

Frozen Plasma Transfusion Practices in Ontario-an Electronic Audit at Five Tertiary Care Hospitals to Inform a Knowledge Translation Strategy to Reduce Inappropriate Plasma Transfusions

Leigh Minuk, MD, Jeannie Callum, MD

Blood (2018) 132 (Supplement 1): 5083.

https://doi.org/10.1182/blood-2018-99-119859

Published: 2018

Journal Articles

A Feasibility Randomized Trial of Red Cell Transfusion Thresholds in Myelodysplasia

Simon Stanworth, MD, Sally Killick, MD, Zoe McQuilten, MD, Marina Karakantza, MD, Heather Smethurst, RSCN RGN, Laura Pankhurst, M.Sc, Renate L Hodge, B.Sc, M.Sc, Valerie Hopkins, B.Sc, Helen Thomas, M.Sc, Alison J Deary, M.Sc, Rena Buckstein, MD FRCPC, Jeannie Callum, MD, Yulia Lin, MD FRCPC, David Bowen, MD PhD

Blood (2018) 132 (Supplement 1): 527.

https://doi.org/10.1182/blood-2018-99-112949

Published: 2018

Journal Articles

Transfusion Reaction Serology: Results of Applied Practices

Robert IS Cohen, BSc, Ana Lima, RN, Alioska Escorcia, HBSc, MSc, MLT, Farzana Tasmin, MPH, MBBS, MT, Yulia Lin, MD FRCPC, Lani Lieberman, MD FRCPC, Jacob Pendergrast, MDFRCPC, Jeannie Callum, MD, Christine M. Cserti-Gazdewich, BSc, MD FRCPC

Blood (2018) 132 (Supplement 1): 1262.

https://doi.org/10.1182/blood-2018-99-110186

Published: 2018

Journal Articles

Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit

Rena Buckstein, MD FRCPC, Rebecca Starkman, Yulia Lin, MD FRCPC, Simon J. Stanworth, MD, David Bowen, MD PhD, Lea Harrison, Sophie Wintrich, Jeannie Callum, MD

Blood (2018) 132 (Supplement 1): 3092.

https://doi.org/10.1182/blood-2018-99-110560

Published: 2018

Journal Articles

Fcγ Receptors I and III on Splenic Macrophages Mediate GPIIb/IIIa Autoantibody-Dependent Phagocytosis of Platelets in Human Immune Thrombocytopenia

Peter A. A. Norris, BSc, George B. Segel, MD, Ulrich J Sachs, MD PhD, Behnaz Bayat, PhD, Gestur Vidarsson, PhD, Rick Kapur, MDPhDMSc, Christine M. Cserti-Gazdewich, BSc, MD FRCPC, Jeannie Callum, MD, Yulia Lin, MD FRCPC, Richard Burack, MD PhD, John W Semple, PhD, Alan H Lazarus, PhD

Blood (2018) 132 (Supplement 1): 129.

https://doi.org/10.1182/blood-2018-99-117650

Published: 2018

Journal Articles

A Retrospective Assessment of Prevention and Treatment of Iron Deficiency Amongst Patients Requiring Peripartum Transfusion

Heather Vandermeulen, MD, Yulia Lin, MD FRCPC, Anne McLeod, MD, Jon Barrett, MD, Michelle Sholzberg, MDM, MSc, FRCPC, Jeannie Callum, MD

Blood (2018) 132 (Supplement 1): 1264.

https://doi.org/10.1182/blood-2018-99-115594

Published: 2018

Journal Articles

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis

Blood (2018) 131 (7): 830–835.

https://doi.org/10.1182/blood-2017-07-796151

Published: 2018

Includes: Supplemental data

Journal Articles

Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid

Abi Vijenthira, MD, Devyani Premkumar, Richard A. Wells, MD DPhil, Jeannie Callum, MD, Yulia Lin, MD, Lisa Chodirker, MD, Martha Lenis, Alexandre Mamedov, Rena Buckstein, MD FRCPC

Blood (2017) 130 (Supplement 1): 1691.

https://doi.org/10.1182/blood.V130.Suppl_1.1691.1691

Published: 2017

Journal Articles

Variations in Red Blood Cell and Frozen Plasma Transfusion Rates Across 60 Ontario Community Hospitals

Judy Qiang, MD, Troy Thompson, BAHSc, Jeannie Callum, MD, Peter H. Pinkerton, MD, Yulia Lin, MD

Blood (2017) 130 (Supplement 1): 4935.

https://doi.org/10.1182/blood.V130.Suppl_1.4935.4935

Published: 2017

Journal Articles

Incidence and Risk Factors for IVIG-Mediated Hemolysis

Jacob Pendergrast, MDFRCPC, Beth Binnington, MSc, Tik Nga Tong, Jeannie Callum, MD, Christine Margaret Cserti-Gazdewich, BSc, MD FRCPC, Wendy Lau, MBBS,FRCPC, Lani Lieberman, MD, Yulia Lin, MD, Katerina Pavenski, MD BSc, FRCPC, Nadine Shehata, MDFRCPC,MSc, Rae Yeung, MD PhD FRCP, Donald R. Branch, PhD

Blood (2017) 130 (Supplement 1): 2398.

https://doi.org/10.1182/blood.V130.Suppl_1.2398.2398

Published: 2017

Journal Articles

Safety of Lumbar Punctures in Adult Oncology Patients with Thrombocytopenia

Shuoyan Ning, MD, Brent Kerbel, MDcandidate, Jeannie Callum, MD, Yulia Lin, MD

Blood (2015) 126 (23): 1141.

https://doi.org/10.1182/blood.V126.23.1141.1141

Published: 2015

Journal Articles

Post-Transfusion Fevers and Post-Reaction Culture Practices at a Large Academic Hospital Transfusion Service: Quality of Information and Calculated Bacterial Contamination Event Rates

Christine M. Cserti-Gazdewich, MD, Jacob M Pendergrast, MD FRCPC, Yulia Lin, MD, Jeannie Callum, MD, Lani D. Lieberman, MD, Alioska Escorcia, MLT, Sandra Ramirez-Arcos, PhD

Blood (2015) 126 (23): 3569.

https://doi.org/10.1182/blood.V126.23.3569.3569

Published: 2015

Journal Articles

Demographics, Baseline Characteristics, and Disease Symptom Burden in RESPONSE-2: A Randomized, Phase 3 Study of Ruxolitinib in Polycythemia Vera Patients (pts) Who Are Resistant to or Intolerant of Hydroxyurea (HU)

Francesco Passamonti, MD, Martin Griesshammer, MD, Michele Cavo, MD, Miklos Egyed, MDPhD Prof., Giulia Benevolo, MD, Timothy Devos, MDPhD, Jeannie Callum, MD, Alessandro M. Vannucchi, MD, Serdar Sivgin, MD, Caroline Bensasson, PhD, Mahmudul Khan, PhD, Nadjat Mounedji, MD, Guray Saydam, MD Prof

Blood (2015) 126 (23): 2807.

https://doi.org/10.1182/blood.V126.23.2807.2807

Published: 2015

NARROW

Randomized, Active-Control Phase 3 Study of Four-Factor Prothrombin Complex Concentrate Versus Frozen Plasma in Bleeding Adult Cardiac Surgery Patients

Optimizing Immunoglobulin Replacement Therapy for Patients with B-Cell Malignancies and Hypogammaglobulinemia: The Investigator-Initiated, International, Randomized Phase II/III Rational Platform Trial, and the Rationalise (STOP IgRT) Domain

Long-Term Effect of Ruxolitinib (RUX) in Inadequately Controlled Polycythemia Vera (PV) without Splenomegaly: 5-Year Results from the Phase 3 Response-2 Study

A Regional Massive Hemorrhage Protocol: Designed with a Modified Delphi Technique to Obtain Consensus

Registration Errors Among Patients Receiving Blood Transfusions: A National Analysis from 2008-2017

Identifying Patterns of Inappropriate Plasma Transfusion Practices Using a Novel Multicenter Electronic Data Audit: Over 80 Percent of Plasma Transfused Is Inappropriate

Ruxolitinib for the Treatment of Inadequately Controlled Polycythemia Vera without Splenomegaly: 156-Week Follow-up from the Phase 3 Response-2 Study

Frozen Plasma Transfusion Practices in Ontario-an Electronic Audit at Five Tertiary Care Hospitals to Inform a Knowledge Translation Strategy to Reduce Inappropriate Plasma Transfusions

A Feasibility Randomized Trial of Red Cell Transfusion Thresholds in Myelodysplasia

Transfusion Reaction Serology: Results of Applied Practices

Forty Percent of MDS Patients Wish They Received Red Blood Cell Transfusions at Higher Hemoglobin Thresholds Than They Currently Are: A Multinational Transfusion Audit

Fcγ Receptors I and III on Splenic Macrophages Mediate GPIIb/IIIa Autoantibody-Dependent Phagocytosis of Platelets in Human Immune Thrombocytopenia

A Retrospective Assessment of Prevention and Treatment of Iron Deficiency Amongst Patients Requiring Peripartum Transfusion

ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis

Rates of Severe Bleeding Are Low in Patients with MDS and Severe Thrombocytopenia and May be Mitigated By Tranexamic Acid

Variations in Red Blood Cell and Frozen Plasma Transfusion Rates Across 60 Ontario Community Hospitals

Incidence and Risk Factors for IVIG-Mediated Hemolysis

Safety of Lumbar Punctures in Adult Oncology Patients with Thrombocytopenia

Post-Transfusion Fevers and Post-Reaction Culture Practices at a Large Academic Hospital Transfusion Service: Quality of Information and Calculated Bacterial Contamination Event Rates

Demographics, Baseline Characteristics, and Disease Symptom Burden in RESPONSE-2: A Randomized, Phase 3 Study of Ruxolitinib in Polycythemia Vera Patients (pts) Who Are Resistant to or Intolerant of Hydroxyurea (HU)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only